Current strategies for managing the patient with sepsis

American Journal of Health-System Pharmacy

Volumn 59, Issue SUPPL. 1, 2002, Pages

  Kuhl, David A ^a  

^a BAPTIST MEMORIAL HOSPITAL   (United States)

Author keywords

Antiinfective agents; Dobutamine; Dopamine; Dosage; Hydrocortisone; Lung diseases; Norepinephrine; Nutrition; Replacement solutions; Sepsis; Steroids, cortico ; Sympathomimetic agents; Thrombolytic agents; Ulcers

Indexed keywords

ACETYLCYSTEINE; ALPHA INTERFERON; ANTITHROMBIN III; BRADYKININ ANTAGONIST; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; GROWTH HORMONE; HYDROCORTISONE; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NORADRENALIN; PROSTAGLANDIN E1; TAUROLIDINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASOCONSTRICTOR AGENT;

ADJUVANT THERAPY; CLINICAL FEATURE; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; FLUID THERAPY; HEMOFILTRATION; HUMAN; LUNG INJURY; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0036165639     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.suppl_1.s9     Document Type: Conference Paper

References (38)

1. Septic shock
2. Current therapy for sepsis
3. Treating patients with severe sepsis
4. Pharmacologic issues in the management of septic shock
5. Severe sepsis and septic shock: Definitions, epidemiology, and clinical manifestations
6. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
7. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: Definition of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients
8. Introduction
9. Definition of sepsis
10. Diagnosis of infection in sepsis
11. Antibiotics in sepsis
12. Source control in the management of sepsis
13. Airway and lung in sepsis
14. Hemodynamic support in septic shock
15. Immunologic therapy in sepsis: Currently available
16. Immunological therapy in sepsis: Experimental therapies
17. Other supportive therapies in sepsis
18. Summary of recommendations
19. Rules of evidence and clinical recommendations on the use of antithrombotic agents
20. Antibiotic selection for patients with septic shock
21. Optimal antimicrobial therapy for sepsis
22. Sepsis: A new hypothesis for pathogenesis of the disease process
23. Practice parameters for hemodynamic support of sepsis in adult patients with sepsis
24. Hemodynamic and oxygen transport monitoring to titrate therapy in septic shock
25. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients
26. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
27. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?
28. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy
29. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure
30. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
31. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, double blind, single center study
32. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group
33. Effect of prolonged methylprednisolone therapyin unresolved acute respiratory distress syndrome: A randomized controlled trial
34. Immunomodulatory therapies in sepsis
35. Clinical trials of mediator-directed therapy in sepsis: What have we learned?
36. Treatment of sepsis: Past and future avenues
37. A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock
38. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin